Logos Global Management’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-410,000
| Closed | -$11.7M | – | 59 |
|
|
2023
Q1 | $11.7M | Sell |
410,000
-250,000
| -38% | -$7.16M | 1.68% | 25 |
|
|
2022
Q4 | $20.6M | Sell |
660,000
-425,251
| -39% | -$13.3M | 2.41% | 19 |
|
|
2022
Q3 | $22M | Buy |
1,085,251
+100,000
| +10% | +$2.03M | 2.71% | 15 |
|
|
2022
Q2 | $15.3M | Sell |
985,251
-400,000
| -29% | -$6.21M | 2.81% | 14 |
|
|
2022
Q1 | $26.5M | Sell |
1,385,251
-279,000
| -17% | -$5.34M | 3.44% | 15 |
|
|
2021
Q4 | $42.1M | Buy |
1,664,251
+504,000
| +43% | +$12.8M | 4.34% | 6 |
|
|
2021
Q3 | $38M | Buy |
+1,160,251
| New | +$38M | 2.74% | 13 |
|